• Je něco špatně v tomto záznamu ?

Confirmation of the GNB4 gene as causal for Charcot-Marie-Tooth disease by a novel de novo mutation in a Czech patient

P. Laššuthová, D. Šafka Brožková, J. Neupauerová, M. Krůtová, R. Mazanec, P. Seeman,

. 2017 ; 27 (1) : 57-60. [pub] 20160922

Jazyk angličtina Země Velká Británie

Typ dokumentu kazuistiky, časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18010911

Grantová podpora
NV16-30206A MZ0 CEP - Centrální evidence projektů

The association of GNB4 with Charcot-Marie-Tooth (CMT) has recently been described in a publication by Soong et al. (Soong, et al., 2013). Here we present a patient with CMT in whom whole exome sequencing identified the mutation p.Lys57Glu in the GNB4 gene (NM_021629.3:c.169A>G). The patient, now 41 years old, is a sporadic case in the family. At the age of 35 he presented with severe disability (CMT neuropathy score 29), profound muscle atrophies, pes cavus and scoliosis. Previously, the patient was tested for PMP22 duplications/deletions and later also with 64 CMT gene panel, with no causal variant found. Subsequently, whole exome sequencing was performed. The p.Lys57Glu in the GNB4 gene was identified as the most probable causal variant, the mutation is not present in the patient's parents, neither in his unaffected sister, therefore we assume that the mutation arose de novo. Taken together, these findings support the causal and pathogenic character of the variant. Our report provides important evidence that GNB4 should become an established CMT gene and our findings confirm the original publication by Soong et al. (2013).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18010911
003      
CZ-PrNML
005      
20180420094558.0
007      
ta
008      
180404s2017 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.nmd.2016.09.010 $2 doi
035    __
$a (PubMed)27908631
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Laššuthová, Petra $u Department of Paediatric Neurology, DNA Lab, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic. Electronic address: petra.lassuthova@fnmotol.cz.
245    10
$a Confirmation of the GNB4 gene as causal for Charcot-Marie-Tooth disease by a novel de novo mutation in a Czech patient / $c P. Laššuthová, D. Šafka Brožková, J. Neupauerová, M. Krůtová, R. Mazanec, P. Seeman,
520    9_
$a The association of GNB4 with Charcot-Marie-Tooth (CMT) has recently been described in a publication by Soong et al. (Soong, et al., 2013). Here we present a patient with CMT in whom whole exome sequencing identified the mutation p.Lys57Glu in the GNB4 gene (NM_021629.3:c.169A>G). The patient, now 41 years old, is a sporadic case in the family. At the age of 35 he presented with severe disability (CMT neuropathy score 29), profound muscle atrophies, pes cavus and scoliosis. Previously, the patient was tested for PMP22 duplications/deletions and later also with 64 CMT gene panel, with no causal variant found. Subsequently, whole exome sequencing was performed. The p.Lys57Glu in the GNB4 gene was identified as the most probable causal variant, the mutation is not present in the patient's parents, neither in his unaffected sister, therefore we assume that the mutation arose de novo. Taken together, these findings support the causal and pathogenic character of the variant. Our report provides important evidence that GNB4 should become an established CMT gene and our findings confirm the original publication by Soong et al. (2013).
650    _2
$a dospělí $7 D000328
650    _2
$a Charcotova-Marieova-Toothova nemoc $x genetika $x patologie $x patofyziologie $7 D002607
650    _2
$a Česká republika $7 D018153
650    _2
$a proteiny vázající GTP - beta-podjednotky $x genetika $7 D044387
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mutace $7 D009154
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šafka Brožková, Dana $u Department of Paediatric Neurology, DNA Lab, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Neupauerová, Jana $u Department of Paediatric Neurology, DNA Lab, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Krůtová, Marcela $u Department of Paediatric Neurology, DNA Lab, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Mazanec, Radim $u Department of Neurology, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
700    1_
$a Seeman, Pavel $u Department of Paediatric Neurology, DNA Lab, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.
773    0_
$w MED00003492 $t Neuromuscular disorders NMD $x 1873-2364 $g Roč. 27, č. 1 (2017), s. 57-60
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27908631 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20180420094700 $b ABA008
999    __
$a ok $b bmc $g 1288396 $s 1007723
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 27 $c 1 $d 57-60 $e 20160922 $i 1873-2364 $m Neuromuscular disorders $n Neuromuscul Disord $x MED00003492
GRA    __
$a NV16-30206A $p MZ0
LZP    __
$a Pubmed-20180404

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...